ALLMERCAP mercaptopurine monohydrate 20 mg/mL oral liquid suspension bottle, Link Medical Products Pty Ltd T A Link Pharmaceuticals , CON-1169

The product(s): will be supplied in the UK approved packaging which has the following differences: the name Xaluprine in place of Allmercap; the active ingredient name is referred to as mercaptopurine instead of mercaptopurine monohydrate; the name and quantity of the active ingredient are not in a cohesive unit with the name of the medicine; the storage statement is not in the permitted format; the Schedule 1 substances aspartame and potassium sorbate are not expressed as required; the sponsor’s name and address are not included on the label and the name of the sponsor is not included on the bottle label.